FR2371430B1 - - Google Patents

Info

Publication number
FR2371430B1
FR2371430B1 FR7734311A FR7734311A FR2371430B1 FR 2371430 B1 FR2371430 B1 FR 2371430B1 FR 7734311 A FR7734311 A FR 7734311A FR 7734311 A FR7734311 A FR 7734311A FR 2371430 B1 FR2371430 B1 FR 2371430B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7734311A
Other versions
FR2371430A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2371430A1 publication Critical patent/FR2371430A1/fr
Application granted granted Critical
Publication of FR2371430B1 publication Critical patent/FR2371430B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems
FR7734311A 1976-11-17 1977-11-15 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines trisubstituees, leur preparation et leurs applications therapeutiques Granted FR2371430A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,965 US4160765A (en) 1976-11-17 1976-11-17 Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (2)

Publication Number Publication Date
FR2371430A1 FR2371430A1 (fr) 1978-06-16
FR2371430B1 true FR2371430B1 (fr) 1980-06-27

Family

ID=24986959

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7734311A Granted FR2371430A1 (fr) 1976-11-17 1977-11-15 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines trisubstituees, leur preparation et leurs applications therapeutiques

Country Status (37)

Country Link
US (1) US4160765A (fr)
JP (3) JPS5363335A (fr)
AR (1) AR224495A1 (fr)
AT (1) AT362379B (fr)
AU (1) AU509754B2 (fr)
BE (1) BE860774A (fr)
BG (1) BG30019A3 (fr)
CA (1) CA1092107A (fr)
CH (1) CH635079A5 (fr)
CS (1) CS219333B2 (fr)
CY (1) CY1246A (fr)
DD (1) DD133563A5 (fr)
DE (1) DE2751258A1 (fr)
DK (1) DK156057C (fr)
ES (1) ES464044A1 (fr)
FI (1) FI67374C (fr)
FR (1) FR2371430A1 (fr)
GB (1) GB1595502A (fr)
HU (1) HU176709B (fr)
IE (1) IE46087B1 (fr)
IL (1) IL53377A (fr)
IN (1) IN150172B (fr)
IT (1) IT1126216B (fr)
LU (1) LU78513A1 (fr)
MX (1) MX4682E (fr)
MY (1) MY8500382A (fr)
NL (2) NL185563C (fr)
NO (1) NO147029C (fr)
PH (2) PH13611A (fr)
PL (1) PL109672B1 (fr)
PT (1) PT67260B (fr)
RO (1) RO72905A (fr)
SE (1) SE436646B (fr)
SG (1) SG31784G (fr)
SU (1) SU976847A3 (fr)
YU (1) YU40490B (fr)
ZA (1) ZA775910B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
ZA792044B (en) * 1978-05-08 1980-05-28 Scherico Ltd Substituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
US4251525A (en) * 1979-05-25 1981-02-17 Smithkline Corporation 3-Allyl-7,8-dihydroxy-6-halo-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
ATE5634T1 (de) * 1979-07-10 1984-01-15 Smithkline Beckman Corporation Synergistische blutdrucksenkende zusammensetzungen.
US4285938A (en) * 1979-10-11 1981-08-25 Smithkline Corporation 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
US4284556A (en) * 1980-01-31 1981-08-18 Smithkline Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4328153A (en) * 1980-07-17 1982-05-04 Smith Kline Corporation Dopaminergic benzazepines
DE3172458D1 (en) * 1981-12-08 1985-10-31 Smithkline Beckman Corp Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
US4705862A (en) * 1984-10-05 1987-11-10 Smithkline Beckman Corporation Chemical processes for 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)oxazolidines
US4782163A (en) * 1984-10-05 1988-11-01 Smithkline Beckman Corporation 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)-oxazolidines
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
KR20010113006A (ko) * 2000-06-15 2001-12-24 주정호 항암제로서 유용한 n-치환된 벤즈아제피닐우레아 유도체및 그의 제조방법
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
GB0412314D0 (en) * 2004-06-02 2004-07-07 Glaxo Group Ltd Compounds
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1781360A1 (fr) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Dispositif de distribution de drogue par aérosol intégrant des conditionnements thermiques actionnés par percussion
US20060194967A1 (en) * 2005-01-24 2006-08-31 Ettore Bigatti Process for the preparation of Fenoldopam Mesylate
WO2008112661A2 (fr) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Unité chauffante à utiliser dans un dispositif d'administration de médicament
CN103172565A (zh) * 2011-12-22 2013-06-26 四川科伦药物研究有限公司 一种手性菲诺多泮的拆分方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH498122A (de) * 1968-02-09 1970-10-31 Geigy Ag J R Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH555831A (de) * 1967-02-17 1974-11-15 Scherico Ltd Verfahren zur herstellung von neuen benzazepinen.
DE1695844C3 (de) * 1967-02-21 1980-01-17 Scherico Ltd., Luzern (Schweiz) l-Phenyl-23,43-tetrahydro-lH^benzazepin-Derivate und sie enthaltende pharmazeutische Zusammensetzungen
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives

Also Published As

Publication number Publication date
ATA816377A (de) 1980-10-15
HU176709B (en) 1981-04-28
AU509754B2 (en) 1980-05-22
RO72905A (fr) 1981-11-04
FI773448A (fi) 1978-05-18
FR2371430A1 (fr) 1978-06-16
AT362379B (de) 1981-05-11
CS219333B2 (en) 1983-03-25
DK500477A (da) 1978-05-18
JPS58113153A (ja) 1983-07-05
CY1246A (en) 1984-08-31
SE7712944L (sv) 1978-05-18
NO147029C (no) 1983-01-19
PH14740A (en) 1981-11-20
JPS5363335A (en) 1978-06-06
NO147029B (no) 1982-10-11
MY8500382A (en) 1985-12-31
FI67374C (fi) 1985-03-11
YU270777A (en) 1983-02-28
PL202177A1 (pl) 1978-09-25
CA1092107A (fr) 1980-12-23
JPS62155218A (ja) 1987-07-10
DE2751258C2 (fr) 1990-01-04
SG31784G (en) 1985-03-08
DK156057C (da) 1989-11-13
PT67260B (en) 1979-04-18
JPS6125697B2 (fr) 1986-06-17
IT1126216B (it) 1986-05-14
NL930026I1 (nl) 1993-06-01
IL53377A0 (en) 1978-01-31
JPS6366808B2 (fr) 1988-12-22
LU78513A1 (fr) 1978-03-20
IE46087L (en) 1978-05-17
IN150172B (fr) 1982-04-07
DE2751258A1 (de) 1978-06-01
FI67374B (fi) 1984-11-30
GB1595502A (en) 1981-08-12
BG30019A3 (en) 1981-03-16
IE46087B1 (en) 1983-02-23
NL185563B (nl) 1989-12-18
DD133563A5 (de) 1979-01-10
IL53377A (en) 1982-09-30
US4160765A (en) 1979-07-10
CH635079A5 (de) 1983-03-15
AU3062677A (en) 1979-05-24
DK156057B (da) 1989-06-19
NL930026I2 (nl) 1993-11-01
SE436646B (sv) 1985-01-14
NO773901L (no) 1978-05-19
PH13611A (en) 1980-08-05
PL109672B1 (en) 1980-06-30
ES464044A1 (es) 1978-08-01
MX4682E (es) 1982-07-28
PT67260A (en) 1977-12-01
SU976847A3 (ru) 1982-11-23
NL7712567A (nl) 1978-05-19
AR224495A1 (es) 1981-12-15
ZA775910B (en) 1978-05-30
BE860774A (fr) 1978-05-16
NL185563C (nl) 1990-05-16
JPS6225658B2 (fr) 1987-06-04
YU40490B (en) 1986-02-28

Similar Documents

Publication Publication Date Title
FR2371430B1 (fr)
CH617305B (fr)
JPS565640B2 (fr)
JPS576446Y2 (fr)
JPS5376459U (fr)
JPS537681U (fr)
JPS5346802U (fr)
JPS5340181U (fr)
JPS5337804U (fr)
JPS5330476U (fr)
JPS5299669U (fr)
JPS52155591U (fr)
JPS5391228U (fr)
CS175502B1 (fr)
DD124831A1 (fr)
CH613552A5 (fr)
DD126087A5 (fr)
DD125952A1 (fr)
CH605017A5 (fr)
DD125387A1 (fr)
DD125293A1 (fr)
DD125237A1 (fr)
DD125161A1 (fr)
DD124264A5 (fr)
DD123805A1 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name